Literature DB >> 25770092

Enhanced Natriuresis and Diuresis in Wistar Rats Caused by the Costimulation of Renal Dopamine D3 and Angiotensin II Type 2 Receptors.

Sufei Yang1, Yu Han1, Shuo Zheng1, Xun Kou1, Laureano D Asico2, Hefei Huang1, Zhao Gao1, Pedro A Jose3, Chunyu Zeng4.   

Abstract

BACKGROUND: The kidney, via its regulation of sodium excretion, which is modulated by humoral factors, including the dopamine and renin-angiotensin systems, keeps the blood pressure in the normal range. We have reported a negative interaction between dopamine D3 and AT1 receptors (D3R and AT1R) in renal proximal tubule (RPT) cells. Here, we studied the interaction between D3R and AT2R in vitro and in vivo. METHODS AND
RESULTS: Stimulation of either the D3R or AT2R, by the intrarenal arterial infusion of PD128907, a D3R agonist, or CGP42112A, an AT2R agonist, induced natriuresis and diuresis that were enhanced by the simultaneous infusion of PD128907 and CGP42112A in Wistar rats. The D3/AT2 receptor interaction was confirmed in in vitro, i.e., stimulation of either the D3R or AT2R inhibited Na(+)-K(+)-ATPase activity that was enhanced by the costimulation of these receptors. D3R and AT2R colocalized and coimmunoprecipitated in kidney and RPT cells (RPTCs). Stimulation of one receptor increased the localization of the other receptor at the plasma cell membrane. ERK1/2-MAPK is involved in the signaling pathway of D3R and AT2R interaction because costimulation of D3R and AT2R significantly increased ERK1/2-MAPK expression in RPTCs; inhibition of ERK1/2-MAPK abolished the inhibition of Na(+)-K(+)-ATPase activity that was enhanced by D3R and AT2R costimulation.
CONCLUSIONS: Our current study indicates that D3R, in combination with AT2R, enhances natriuresis and diuresis, via ERK1/2-MAPK pathway, that may be involved in the regulation of blood pressure. © American Journal of Hypertension, Ltd 2015. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  angiotensin II type 2 receptor; blood pressure; dopamine D3 receptor; hypertension; kidney; kidney tubules; proximal.

Mesh:

Substances:

Year:  2015        PMID: 25770092      PMCID: PMC4675840          DOI: 10.1093/ajh/hpv018

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  40 in total

1.  First reported nonpeptide AT1 receptor agonist (L-162,313) acts as an AT2 receptor agonist in vivo.

Authors:  Yiqian Wan; Charlotta Wallinder; Berndt Johansson; Mathias Holm; A K Mahalingam; Xiongyu Wu; Milad Botros; Anders Karlén; Anders Pettersson; Fred Nyberg; Lars Fändriks; Anders Hallberg; Mathias Alterman
Journal:  J Med Chem       Date:  2004-03-11       Impact factor: 7.446

2.  Intrarenal dopamine D1-like receptor stimulation induces natriuresis via an angiotensin type-2 receptor mechanism.

Authors:  Leslie J Salomone; Nancy L Howell; Helen E McGrath; Brandon A Kemp; Susanna R Keller; John J Gildea; Robin A Felder; Robert M Carey
Journal:  Hypertension       Date:  2006-11-20       Impact factor: 10.190

3.  In vitro autoradiography reveals predominantly AT1 angiotensin II receptors in rat kidney.

Authors:  J Zhuo; K Song; P J Harris; F A Mendelsohn
Journal:  Ren Physiol Biochem       Date:  1992 Sep-Oct

4.  Functional selectivity of allosteric interactions within G protein-coupled receptor oligomers: the dopamine D1-D3 receptor heterotetramer.

Authors:  Xavier Guitart; Gemma Navarro; Estefania Moreno; Hideaki Yano; Ning-Sheng Cai; Marta Sánchez-Soto; Sandeep Kumar-Barodia; Yamini T Naidu; Josefa Mallol; Antoni Cortés; Carme Lluís; Enric I Canela; Vicent Casadó; Peter J McCormick; Sergi Ferré
Journal:  Mol Pharmacol       Date:  2014-08-05       Impact factor: 4.436

5.  Angiotensin II AT2 receptors inhibit proximal tubular Na+-K+-ATPase activity via a NO/cGMP-dependent pathway.

Authors:  Amer C Hakam; Tahir Hussain
Journal:  Am J Physiol Renal Physiol       Date:  2005-12-27

6.  Angiotensin-II type 1 receptor-mediated hypertension in D4 dopamine receptor-deficient mice.

Authors:  Martin J Bek; Xiaoyan Wang; Laureano D Asico; John E Jones; Shaopeng Zheng; Xiaoxi Li; Gilbert M Eisner; David K Grandy; Robert M Carey; Patricio Soares-da-Silva; Pedro A Jose
Journal:  Hypertension       Date:  2005-12-27       Impact factor: 10.190

7.  Relative affinity of angiotensin peptides and novel ligands at AT1 and AT2 receptors.

Authors:  Sanja Bosnyak; Emma S Jones; Arthur Christopoulos; Marie-Isabel Aguilar; Walter G Thomas; Robert E Widdop
Journal:  Clin Sci (Lond)       Date:  2011-10       Impact factor: 6.124

Review 8.  The intrarenal renin-angiotensin and dopaminergic systems: control of renal sodium excretion and blood pressure.

Authors:  Robert M Carey
Journal:  Hypertension       Date:  2013-03       Impact factor: 10.190

9.  Renal D3 dopamine receptor stimulation induces natriuresis by endothelin B receptor interactions.

Authors:  Chunyu Zeng; Laureano D Asico; Changqing Yu; Van Anthony M Villar; Weibin Shi; Yingjin Luo; Zheng Wang; Duofen He; Yan Liu; Lan Huang; Chengming Yang; Xukai Wang; Ulrich Hopfer; Gilbert M Eisner; Pedro A Jose
Journal:  Kidney Int       Date:  2008-06-11       Impact factor: 10.612

10.  Effects of costimulation of dopamine D1- and D2-like receptors on renal function.

Authors:  P A Jose; L D Asico; G M Eisner; F Pocchiari; C Semeraro; R A Felder
Journal:  Am J Physiol       Date:  1998-10
View more
  9 in total

1.  GRK4-mediated adiponectin receptor-1 phosphorylative desensitization as a novel mechanism of reduced renal sodium excretion in hypertension.

Authors:  Yan Zhang; Shaoxiong Wang; Hefei Huang; Andi Zeng; Yu Han; Cindy Zeng; Shuo Zheng; Hongmei Ren; Yajing Wang; Yu Huang; Pedro A Jose; Xin-Liang Ma; Chunyu Zeng; Ken Chen
Journal:  Clin Sci (Lond)       Date:  2020-09-30       Impact factor: 6.124

Review 2.  Update on angiotensin AT2 receptors.

Authors:  Robert M Carey
Journal:  Curr Opin Nephrol Hypertens       Date:  2017-03       Impact factor: 2.894

Review 3.  The Angiotensin AT2 Receptor: From a Binding Site to a Novel Therapeutic Target.

Authors:  U Muscha Steckelings; Robert E Widdop; Edward D Sturrock; Lizelle Lubbe; Tahir Hussain; Elena Kaschina; Thomas Unger; Anders Hallberg; Robert M Carey; Colin Sumners
Journal:  Pharmacol Rev       Date:  2022-10       Impact factor: 18.923

Review 4.  Inverse Salt Sensitivity of Blood Pressure: Mechanisms and Potential Relevance for Prevention of Cardiovascular Disease.

Authors:  Robin A Felder; John J Gildea; Peng Xu; Wei Yue; Ines Armando; Robert M Carey; Pedro A Jose
Journal:  Curr Hypertens Rep       Date:  2022-06-16       Impact factor: 4.592

Review 5.  Kidney tubules: intertubular, vascular, and glomerular cross-talk.

Authors:  David A Ferenbach; Joseph V Bonventre
Journal:  Curr Opin Nephrol Hypertens       Date:  2016-05       Impact factor: 2.894

Review 6.  Renal Dopamine Receptors and Oxidative Stress: Role in Hypertension.

Authors:  Jian Yang; Van Anthony M Villar; Pedro A Jose; Chunyu Zeng
Journal:  Antioxid Redox Signal       Date:  2020-05-29       Impact factor: 8.401

7.  Downregulation of Renal G Protein-Coupled Receptor Kinase Type 4 Expression via Ultrasound-Targeted Microbubble Destruction Lowers Blood Pressure in Spontaneously Hypertensive Rats.

Authors:  Hefei Huang; Xiaolong Li; Shuo Zheng; Yue Chen; Caiyu Chen; Jialiang Wang; Haipeng Tong; Lin Zhou; Jian Yang; Chunyu Zeng
Journal:  J Am Heart Assoc       Date:  2016-10-06       Impact factor: 5.501

Review 8.  The Role of the Renal Dopaminergic System and Oxidative Stress in the Pathogenesis of Hypertension.

Authors:  Waleed N Qaddumi; Pedro A Jose
Journal:  Biomedicines       Date:  2021-02-01

Review 9.  Angiotensin Type-2 Receptors: Transducers of Natriuresis in the Renal Proximal Tubule.

Authors:  Robert M Carey; Helmy M Siragy; John J Gildea; Susanna R Keller
Journal:  Int J Mol Sci       Date:  2022-02-19       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.